SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-130567
Filing Date
2018-04-25
Accepted
2018-04-25 11:32:03
Documents
7
Effectiveness Date
2018-04-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A d538309ddefa14a.htm DEFA14A 30619
2 GRAPHIC g538309g05e15.jpg GRAPHIC 23408
3 GRAPHIC g538309g16q56.jpg GRAPHIC 13701
4 GRAPHIC g538309g22d56.jpg GRAPHIC 25156
5 GRAPHIC g538309g62d05.jpg GRAPHIC 24728
6 GRAPHIC g538309g76c99.jpg GRAPHIC 32714
7 GRAPHIC g538309g87n84.jpg GRAPHIC 13084
  Complete submission text file 0001193125-18-130567.txt   215156
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38276 | Film No.: 18773301
SIC: 2834 Pharmaceutical Preparations